Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1844 1
1909 1
1928 1
1946 3
1949 1
1950 4
1951 2
1952 3
1953 2
1954 2
1955 4
1957 1
1958 2
1960 1
1963 53
1964 61
1965 26
1966 3
1967 4
1968 2
1969 5
1970 1
1971 4
1972 5
1973 6
1974 2
1975 7
1976 15
1977 14
1978 20
1979 34
1980 45
1981 60
1982 92
1983 106
1984 168
1985 178
1986 202
1987 329
1988 323
1989 497
1990 555
1991 540
1992 714
1993 770
1994 811
1995 852
1996 904
1997 1008
1998 1030
1999 1077
2000 1210
2001 1240
2002 1301
2003 1369
2004 1359
2005 1327
2006 1283
2007 1328
2008 1300
2009 1175
2010 1257
2011 1305
2012 1276
2013 1437
2014 1423
2015 1523
2016 1458
2017 1474
2018 1555
2019 1626
2020 2564
2021 2937
2022 2700
2023 2414
2024 881

Text availability

Article attribute

Article type

Publication date

Search Results

45,137 results

Results by year

Filters applied: . Clear all
Page 1
ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management.
Overlack A. Overlack A. Drug Saf. 1996 Jul;15(1):72-8. doi: 10.2165/00002018-199615010-00006. Drug Saf. 1996. PMID: 8862965 Review.
A dry, tickly and often bothersome cough is the most common adverse effect of ACE inhibitors. Recent studies indicate that cough may develop in around 10% of the patients treated with ACE inhibitors. ...Replacement by another ACE inhibitor should not be tried …
A dry, tickly and often bothersome cough is the most common adverse effect of ACE inhibitors. Recent studies indicate that cough may …
Angiotensin converting enzyme (ACE).
Khurana V, Goswami B. Khurana V, et al. Clin Chim Acta. 2022 Jan 1;524:113-122. doi: 10.1016/j.cca.2021.10.029. Epub 2021 Oct 30. Clin Chim Acta. 2022. PMID: 34728179 Review.
BACKGROUND: Angiotensin converting enzyme (ACE) was isolated as a 'hypertensinconverting enzyme'. There have been considerable advances in understanding the metabolic role of ACE in the body. ...CONCLUSIONS: More studies need to be carried out in order to validate t …
BACKGROUND: Angiotensin converting enzyme (ACE) was isolated as a 'hypertensinconverting enzyme'. There have been considerable advanc …
Pathophysiology of COVID-19: Everywhere You Look You Will See ACE(2)!
Cousin VL, Giraud R, Bendjelid K. Cousin VL, et al. Front Med (Lausanne). 2021 Aug 27;8:694029. doi: 10.3389/fmed.2021.694029. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34513868 Free PMC article. Review.
Angiotensin converting enzyme 2 (ACE(2)) seems to be a central actor in the pathophysiology of SARS-Cov-2 infection. ...It seems that all these risks factors are linked to an increased level of ACE(2) and/or imbalance in ACE/ACE(2)....
Angiotensin converting enzyme 2 (ACE(2)) seems to be a central actor in the pathophysiology of SARS-Cov-2 infection. ...It seems that …
Exploring the Impact of ACE Inhibition in Immunity and Disease.
Oosthuizen D, Sturrock ED. Oosthuizen D, et al. J Renin Angiotensin Aldosterone Syst. 2022 Aug 4;2022:9028969. doi: 10.1155/2022/9028969. eCollection 2022. J Renin Angiotensin Aldosterone Syst. 2022. PMID: 36016727 Free PMC article. Review.
Patients using ACE inhibitors may be more at risk of postsurgical complications as ACE inhibition in human neutrophils results in decreased ROS and phagocytosis whilst angiotensin receptor blockers (ARBs) have no effect. ...Understanding ACE inhibition in imm …
Patients using ACE inhibitors may be more at risk of postsurgical complications as ACE inhibition in human neutrophils results …
Evaluating the association between genetically proxied ACE inhibition and dementias.
Nassan M, Daghlas I, Piras IS, Rogalski E, Reus LM, Pijnenburg Y, Cuddy LK, Saxena R, Mesulam MM, Huentelman M. Nassan M, et al. Alzheimers Dement. 2023 Sep;19(9):3894-3901. doi: 10.1002/alz.13062. Epub 2023 Apr 6. Alzheimers Dement. 2023. PMID: 37023267
INTRODUCTION: Angiotensin-converting enzyme (ACE) has been implicated in the metabolism of amyloid beta; however, the causal effect of ACE inhibition on risk of Alzheimer's disease (AD) dementia and other common dementias is largely unknown. ...The results suggest a …
INTRODUCTION: Angiotensin-converting enzyme (ACE) has been implicated in the metabolism of amyloid beta; however, the causal effect o …
ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.
Rahimi Z. Rahimi Z. J Nephropathol. 2012 Oct;1(3):143-51. doi: 10.5812/nephropathol.8109. Epub 2012 Oct 1. J Nephropathol. 2012. PMID: 24475405 Free PMC article. Review.
ACE DD genotype is associated with the highest systemic and renal ACE levels compared with the lowest ACE activity in carriers of II genotype. ...Also, association between ACE I/D polymorphism and response to ACE inhibitor and angiotensin II rec
ACE DD genotype is associated with the highest systemic and renal ACE levels compared with the lowest ACE activity in c
The action-sentence compatibility effect (ACE): Meta-analysis of a benchmark finding for embodiment.
Winter A, Dudschig C, Miller J, Ulrich R, Kaup B. Winter A, et al. Acta Psychol (Amst). 2022 Oct;230:103712. doi: 10.1016/j.actpsy.2022.103712. Epub 2022 Sep 11. Acta Psychol (Amst). 2022. PMID: 36103797 Free article. Review.
However, recently there have been difficulties in extending or even in reliably replicating the ACE. The conflicting findings concerning the ACE and its extensions lead to the discussion of whether the ACE is indeed a reliable effect. ...Additionally, an anal …
However, recently there have been difficulties in extending or even in reliably replicating the ACE. The conflicting findings concern …
Overview of the angiotensin-converting-enzyme inhibitors.
Piepho RW. Piepho RW. Am J Health Syst Pharm. 2000 Oct 1;57 Suppl 1:S3-7. doi: 10.1093/ajhp/57.suppl_1.S3. Am J Health Syst Pharm. 2000. PMID: 11030016 Review.
ACE is found in numerous tissues, and there is increasing evidence of differences among ACE inhibitors in their ability to inhibit tissue ACE. ...Lisinopril is the only ACE inhibitor that does not require hepatic metabolism. In the selection of an A
ACE is found in numerous tissues, and there is increasing evidence of differences among ACE inhibitors in their ability to inh
Tissue ACE phenotyping in lung cancer.
Danilov SM, Metzger R, Klieser E, Sotlar K, Trakht IN, Garcia JGN. Danilov SM, et al. PLoS One. 2019 Dec 26;14(12):e0226553. doi: 10.1371/journal.pone.0226553. eCollection 2019. PLoS One. 2019. PMID: 31877149 Free PMC article.
METHODOLOGY: ACE phenotyping included: 1) ACE immunohistochemistry with specific and well-characterized monoclonal antibodies (mAbs) to ACE; 2) ACE activity measurement with two ACE substrates (HHL, ZPHL); 3) calculation of ACE substrates …
METHODOLOGY: ACE phenotyping included: 1) ACE immunohistochemistry with specific and well-characterized monoclonal antibodies …
ACE phenotyping in Gaucher disease.
Danilov SM, Tikhomirova VE, Metzger R, Naperova IA, Bukina TM, Goker-Alpan O, Tayebi N, Gayfullin NM, Schwartz DE, Samokhodskaya LM, Kost OA, Sidransky E. Danilov SM, et al. Mol Genet Metab. 2018 Apr;123(4):501-510. doi: 10.1016/j.ymgme.2018.02.007. Epub 2018 Feb 17. Mol Genet Metab. 2018. PMID: 29478818 Free PMC article.
METHODS: ACE phenotyping included 1) immunohistochemical staining for ACE; 2) measuring ACE activity with two substrates (HHL and ZPHL); 3) calculating the ratio of the rates of substrate hydrolysis (ZPHL/HHL ratio); 4) assessing the conformational fingerprin …
METHODS: ACE phenotyping included 1) immunohistochemical staining for ACE; 2) measuring ACE activity with two substrate …
45,137 results
You have reached the last available page of results. Please see the User Guide for more information.